Vance K W, Campo M S, Morgan I M
Beatson Institute for Cancer Research, CRC Beatson Laboratories, Glasgow G61 1BD, Scotland.
J Virol. 2001 Mar;75(6):2829-38. doi: 10.1128/JVI.75.6.2829-2838.2001.
The long control regions (LCRs) of mucosal epitheliotropic papillomaviruses have similar organizations: a promoter region, an enhancer region, and a highly conserved distribution of E2 DNA binding sites (C. Desaintes and C. Demeret, Semin. Cancer Biol. 7:339--347, 1996). The enhancer of these viruses is epithelial cell specific, as it fails to activate transcription from heterologous promoters in nonepithelial cell types (B. Gloss, H. U. Bernard, K. Seedorf, and G. Klock, EMBO J. 6:3735--3743, 1987). Using the bovine papillomavirus type 4 (BPV-4) LCR and a bovine primary cell system, we have shown previously that a level of epithelial specificity resides in a papillomavirus promoter region. The BPV-4 promoter shows an enhanced response to transcriptional activators in epithelial cells compared with that of fibroblasts (K. W. Vance, M. S. Campo, and I. M. Morgan, J. Biol. Chem. 274:27839--27844, 1999). A chimeric lcr/tk promoter suggests that the upstream BPV-4 promoter region determines the cell-type-selective response of this promoter in fibroblasts and keratinocytes. Promoter deletion analysis identified two novel repressor elements that are, at least in part, responsible for mediating the differential response of this promoter to upstream activators in fibroblasts and keratinocytes. One of these elements, promoter repressor element 2 (PRE-2), is conserved in position and sequence in the related mucosal epitheliotropic papillomaviruses, BPV-3 and BPV-6. PRE-2 functions in cis to repress the basal activity of the simian virus 40 promoter and binds a specific protein complex. We identify the exact nucleotides necessary for binding and correlate loss of binding with loss of transcriptional repression. We also incorporate these mutations into the BPV-4 promoter and demonstrate an enhanced response of the mutated promoter to E2 in fibroblasts. The DNA binding protein in the detected complex is shown to have a molecular mass of approximately 50 kDa. The PRE-2 binding protein represents a novel transcriptional repressor and regulator of papillomavirus transcription.
黏膜嗜上皮乳头瘤病毒的长控制区(LCRs)具有相似的结构:一个启动子区域、一个增强子区域以及E2 DNA结合位点的高度保守分布(C. Desaintes和C. Demeret,《癌症生物学综述》7:339 - 347,1996年)。这些病毒的增强子具有上皮细胞特异性,因为它无法激活非上皮细胞类型中异源启动子的转录(B. Gloss、H. U. Bernard、K. Seedorf和G. Klock,《欧洲分子生物学组织杂志》6:3735 - 3743,1987年)。利用牛乳头瘤病毒4型(BPV - 4)LCR和牛原代细胞系统,我们之前已经表明乳头瘤病毒启动子区域存在一定水平的上皮特异性。与成纤维细胞相比,BPV - 4启动子在上皮细胞中对转录激活因子的反应增强(K. W. Vance、M. S. Campo和I. M. Morgan,《生物化学杂志》274:27839 - 27844,1999年)。一个嵌合的lcr/tk启动子表明,BPV - 4启动子上游区域决定了该启动子在成纤维细胞和角质形成细胞中的细胞类型选择性反应。启动子缺失分析确定了两个新的抑制元件,它们至少部分负责介导该启动子在成纤维细胞和角质形成细胞中对上游激活因子的不同反应。其中一个元件,启动子抑制元件2(PRE - 2),在相关的黏膜嗜上皮乳头瘤病毒BPV - 3和BPV - 6的位置和序列上是保守的。PRE - 2顺式作用以抑制猿猴病毒40启动子的基础活性,并结合一种特定的蛋白质复合物。我们确定了结合所需的确切核苷酸,并将结合的丧失与转录抑制的丧失相关联。我们还将这些突变引入BPV - 4启动子,并证明突变启动子在成纤维细胞中对E2的反应增强。检测到的复合物中的DNA结合蛋白显示分子量约为50 kDa。PRE - 2结合蛋白代表一种新的乳头瘤病毒转录抑制因子和调节因子。